FDA “Xes” Letter Categories For Pregnancy Labels; Data Collection Drives Reg

FDA's proposed rule to update the format of the pregnancy and lactation sections of drug labeling does not require the firms collect new data about their products, but the agency is hoping to use various mechanisms to encourage them to do so